𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluating the potential of polymer nanoparticles for oral delivery of paclitaxel in drug-resistant cancer

✍ Scribed by V. Bhardwaj; J. A. Plumb; J. Cassidy; M. N. V. Ravi Kumar


Book ID
107678385
Publisher
Springer Vienna
Year
2010
Tongue
English
Weight
174 KB
Volume
1
Category
Article
ISSN
1868-6958

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Development and in vivo evaluation of an
✍ Javed Iqbal; Federica Sarti; Glen Perera; Andreas Bernkop-SchnΓΌrch πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 221 KB

The aim of the present study was to investigate the effect of poly(acrylic acid)-cysteine (PAA-cysteine) exhibiting a molecular mass of 100 and 250 kDa and reduced glutathione (GSH) on the absorption of the P-glycoprotein (P-gp) and cytochrome P450 (CYP450) substrate paclitaxel in vitro and in vivo.

In vitro evaluation of novel polymer-coa
✍ Maham Rahimi; Aniket Wadajkar; Khaushik Subramanian; Monet Yousef; Weina Cui; Je πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 839 KB

## From the clinical editor: In this paper, previously uncharacterized magnetic nanoparticles were synthesized using silane-coated mnps as a template for radical polymerization of n-isopropylacrylamide, acrylamide, and allylamine. various properties of these nanoparticles were evaluated in vitro fo

Polymeric microspheres for drug delivery
✍ Sandra Kockisch; Gareth D. Rees; Simon A. Young; John Tsibouklis; John D. Smart πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 288 KB πŸ‘ 2 views

Polymeric microparticles were fabricated from Carbopol, polycarbophil, chitosan, or Gantrez using a "water-in-oil emulsification" solvent evaporation method. Mean particle sizes, as determined by laser diffraction, were in the range 23-38 microm. Electron microscopy revealed that all microparticles

A novel system for evaluation of drug mi
✍ Daniel A. Tatosian; Michael L. Shuler πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 638 KB

## Abstract Multidrug resistant (MDR) cancer is difficult to treat. Chemicals that are effective MDR modulators have never exited clinical trials as FDA approved products due to side effects. It has been hypothesized that using a combination of chemotherapeutics with a mixture of MDR modulators (ea